UWSpace is currently experiencing technical difficulties resulting from its recent migration to a new version of its software. These technical issues are not affecting the submission and browse features of the site. UWaterloo community members may continue submitting items to UWSpace. We apologize for the inconvenience, and are actively working to resolve these technical issues.
 

Endocrine Regulation of Phosphate Homeostasis

Loading...
Thumbnail Image

Date

2018

Authors

Brown, Ronald B.
Razzaque, Mohammed S.

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier

Abstract

Phosphate, a component of nucleic acids, DNA and RNA, is incorporated in the structure of phospholipids in cell membranes, and is involved in many biological functions such as cell signaling, energy metabolism, and bone mineralization. Phosphate homeostasis is regulated by intestinal phosphate absorption, renal phosphate reabsorption, and skeletal phosphate resorption. Renal and intestinal transport of inorganic phosphate is controlled by sodium-phosphate cotransporters. Endocrine regulators that target bone, kidneys, and intestines during phosphate homeostasis include parathyroid hormone, vitamin D, fibroblast growth factor 23 (FGF23), and Klotho. Dysregulated serum phosphate falls within two categories: hypophosphatemia and hyperphosphatemia. Some genetic disorders such as hypophosphatemic rickets overexpress FGF23, inhibiting renal reabsorption of inorganic phosphate, while other disorders such as familial tumor calcinosis inhibit the expression of FGF23, causing hyperphosphatemia. Conditions associated with phosphate toxicity include chronic kidney disease, vascular calcification, tumorigenesis, and premature aging.

Description

author's chapter in edited work

Keywords

aging, FGF23, klotho, phosphate, vascular calcification, vitamin D

LC Keywords

Citation